Analyzing the impact of Th17 cells on cervical cancer cells, we found that Th17 cells reduced the responsiveness of cervical cancer cells toward cisplatin, irradiation, and combined treatment in an IL‐17‐dependent manner. The gene discussed is IL17A; the disease is cervical cancer.